reports
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholde...
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting Mechelen, Belgium; March 27, 2025, 21:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2024 and announces its Annual Shareholders’ Meeting (AGM) to be held on Tuesday, April 29, 2025 at 14:00 CET at the registered office of the Company. The annual report for the financial year 2024, including a review of figures and performance, is available online at and can also be downloaded as PDF. The annual 2024 Form 20-F filing with the ...
Galapagos publiceert 2024 jaarverslag en kondigt jaarlijkse Gewone Alg...
Galapagos publiceert 2024 jaarverslag en kondigt jaarlijkse Gewone Algemene Vergadering aan Mechelen, België; 27 maart 2025, 21:01 CET; gereglementeerde informatie - Galapagos NV (Euronext & NASDAQ: GLPG) publiceert vandaag haar jaarverslag over het boekjaar 2024 en kondigt haar jaarlijkse Gewone Algemene Vergadering (AV) aan die zal worden gehouden op dinsdag 29 april 2025 om 14:00 CET (Belgische tijd) op de zetel van de Vennootschap.Het jaarverslag over het boekjaar 2024, inclusief een overzicht van de cijfers en prestaties, is online beschikbaar op en kan ook als PDF gedownload worden. H...
Galapagos to Present at Upcoming Investor Conferences
Galapagos to Present at Upcoming Investor Conferences Mechelen, Belgium; February 24, 2025, 22:01 CET – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced that its management will present at the following investor conferences in March:TD Cowen 45th Annual Healthcare Conference Date: Tuesday, March 4, 2025Location: Boston, MACorporate Presentation: 1:50 - 2:20 PM ET / 7:50 - 8:20 PM CETLive Webcast Link: Barclays 27th Annual Global Healthcare ConferenceDate: Wednesday,...
Galapagos presenteert op komende investeerdersconferenties
Galapagos presenteert op komende investeerdersconferenties Mechelen, België; 24 februari 2025, 22:01 CET - Galapagos NV (Euronext & NASDAQ: GLPG), een wereldwijd biotechnologiebedrijf toegewijd aan het verbeteren van de uitkomsten voor patiënten door middel van baanbrekende wetenschap en innovatie, heeft vandaag aangekondigd dat haar management zal presenteren op de volgende investeerdersconferenties in maart: TD Cowen 45th Annual Healthcare Conference Datum: dinsdag 4 maart 2025Locatie: Boston, MABedrijfspresentatie: 13:50 - 14:20 ET / 19:50 – 20:20 CET Live Webcast Link: Barclays 27th Ann...
Galapagos receives transparency notification and 13D filing from Tang ...
Galapagos receives transparency notification and 13D filing from Tang Capital Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital. Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on February 14, 2025 on behalf of Mr. Kevin Tang, Tang Capital Management, LLC (“TCM”), Tang Capital Partners, LP (“TCP”), Tang Capital Partners International, LP (“TCPI”), and Tang Capital Partners III, Inc. (“TCP III”), who notified us th...
Galapagos ontvangt transparantieverklaring en 13D-filing van Tang Capi...
Galapagos ontvangt transparantieverklaring en 13D-filing van Tang Capital Mechelen, België; 17 februari 2025, 22:01 CET; gereglementeerde informatie - Galapagos NV (Euronext & NASDAQ: GLPG) heeft een kennisgeving van belangrijke deelneming en 13D filing ontvangen van Tang Capital. Overeenkomstig de Belgische transparantiewetgeving1 heeft Galapagos op 14 februari 2025 een kennisgeving van belangrijke deelneming ontvangen in naam van Dhr. Kevin Tang, Tang Capital Management, LLC ("TCM"), Tang Capital Partners, LP ("TCP"), Tang Capital Partners International, LP ("TCPI"), en Tang Capital Part...
- Hilde Van Boxstael
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
- Baptiste Lebacq
- Klaus Ringel
- Thomas Zlowodzki
TKA THYSSENKRUPP AG
CRI CHARGEURS SA
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
DKSH DKSH HOLDING AG
SSAB A SSAB AB CLASS A
TFI TELEVISION FRANCAISE 1 SA
MERY MERCIALYS SA
SZG SALZGITTER AG
LSS LECTRA SA
VOE VOESTALPINE AG
ACX ACERINOX SA
BAMNB KONINKLIJKE BAM GROEP NV
ERA ERAMET SA
NDA AURUBIS AG
TPS ORANGE POLSKA S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
XIL XILAM ANIMATION SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
GLPG GALAPAGOS NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
PWG PRODWAYS GROUP SA
ALFEN ALFEN NV
AEDAS AEDAS HOMES SA
ALHGR HOFFMANN GREEN CEMENT TECHNOLOGIES SA
FLOW FLOW TRADERS LTD
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
- Baptiste Lebacq
- Klaus Ringel
- Thomas Zlowodzki
TKA THYSSENKRUPP AG
CRI CHARGEURS SA
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
DKSH DKSH HOLDING AG
SSAB A SSAB AB CLASS A
TFI TELEVISION FRANCAISE 1 SA
MERY MERCIALYS SA
SZG SALZGITTER AG
LSS LECTRA SA
VOE VOESTALPINE AG
ACX ACERINOX SA
BAMNB KONINKLIJKE BAM GROEP NV
ERA ERAMET SA
NDA AURUBIS AG
TPS ORANGE POLSKA S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
XIL XILAM ANIMATION SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
GLPG GALAPAGOS NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
PWG PRODWAYS GROUP SA
ALFEN ALFEN NV
AEDAS AEDAS HOMES SA
ALHGR HOFFMANN GREEN CEMENT TECHNOLOGIES SA
FLOW FLOW TRADERS LTD
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Michiel Declercq
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Damien Choplain
- Martial Descoutures
- Jacob Mekhael
Galapagos FY24 update outlines path to market for lead CAR-T
Galapagos reported FY24 results which came with a pipeline prioritisation providing clarity on the path to market lead program GLPG5101 (CD19 CAR-T). With pivotal development planned for 2026 in 8 B-cell malignancies and a first approval targeted for 2028, Galapagos' CAR-T plans are shaping up. YE24 cash came in at € 3.3b and Galapagos will have 500m following the business split announced in January, sufficient to fund the company to reach its next inflection milestones and we expect renewed int...
- Damien Choplain
- Martial Descoutures
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter B...
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein Focusing on accelerating GLPG5101 program, expanding to eight indications with significant unmet needs, and aiming for first approval by 2028 Plan to separate into two companies listed on Nasdaq and Euronext, with SpinCo to build a pipeline through deals and Galapagos to advance novel cell therapies for cance...
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft ee...
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal Overtuigende klinische resultaten voor GLPG5101 in drie NHL-indicaties onderstrepen het potentieel van het innovatieve gedecentraliseerde celtherapieplatform voor de levering van verse, fitte cellen met een mediane vein-to-vein tijd van zeven dagen Focus op versnelling van het GLPG5101 programma, met uitbreiding naar acht indicaties met grote onbeantwoorde behoeften, en streven naar eerste goedkeuring in 2028 Plan om te splitsen in twee bedrijven, genoteerd op Nasdaq en Eurone...
- Jacob Mekhael
Galapagos Conference call feedback: Business split creates freedom for...
Yesterday, Galapagos announced that the company will be split into 2 public entities being i) Galapagos (GLPG 2.0), which will solely focus on the cell therapy program while gaining freedom from the Gilead agreement, and ii) SpinCo, with new management and € 2.45b to develop a new pipeline using BD in collaboration with Gilead. Below we provide our key takeaways from the conference call and our 1-1 interaction with management.
- Baptiste Salaville
- Emira Sagaama
- Emmanuel Matot
- Jerôme Bodin
- Baptiste Salaville
- Bruno Cavalier
- Emira Sagaama
- Emmanuel Matot
- Jerôme Bodin
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.